2019 Novel Coronavirus (COVID-19) With Influenza A, Influenza B and Respiratory Syncytial Virus, NAA (draw in office only)

Use: Results are for the identification and differentiation of RNA from SARS-CoV-2, Influenza A, Influenza B and RSV.

Limitations: This assay is intended for use only under the Food and Drug Administration's Emergency Use Authorization.

Methodology:  Nucleic Acid Amplification (NAA)

***This test is only available to practitioners that collect specimens in office ***